Swedish native Hakan Edstrom labored for years as chief operating officer at MannKind Corp., a Valencia company established in 1991 that sought for decades to develop a breakthrough method of insulin delivery for diabetics. The company, without any products on the market, survived on nearly $1 billion in investments from founder and chief executive Alfred Mann...

Subscribe to get the full story.


Are you a subscriber? Sign In